Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome
About the study
This is a non-interventional, multinational, multi-centre study with primary data collection, to further document the safety and efficacy of osilodrostat administered in routine clinical practice in patients treated with osilodrostat for endogenous Cushing's Syndrome
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
- Written informed consent obtained prior to registration of any patient data
- Male or female patients aged 18 years or older with endogenous CS treated with osilodrostat. Treatment with osilodrostat can either be initiated at the first visit of the study or can have been initiated before screening.
EXCLUSION CRITERIA
Exclusion Criteria:
- Patients with exogenous CS
- Patients with Pseudo CS
- Patients participating in an interventional clinical trial with an investigational drug.
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Endogenous Cushing's Syndrome
Age (in years)
18+
Participants needed
100
Est. Completion Date
Feb 28, 2029
Treatment type
Observational
Sponsor
RECORDATI GROUP
ClinicalTrials.gov identifier
NCT05382156
Study number
LCI699-RECAG-PASS-0572
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?